Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Second Reading on the UK Drug Bill in the House of Commons
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Craigbadon Sep 15, 2016 8:56pm
101 Views
Post# 25243038

RE:Second Reading on the UK Drug Bill in the House of Commons

RE:Second Reading on the UK Drug Bill in the House of CommonsCould be an early Christmas present! The "growth" was supposed to come from the Uk. This could be the nail in the coffin. Government in the Uk works quick, the loophole was just exposed a short time ago. They better sell this dumpster fire quick before private equity finds out about the upcoming price controls if they thought brexit was a bump! Lol

LaticelnExile wrote: ... will be on October 5, 2016!  

Who on this board said something about 2017 ?  


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities